Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NSF updates standards for GMPs

This article was originally published in The Tan Sheet

Executive Summary

NSF International adds the good manufacturing practices requirements FDA published for supplement products in June 2007 to its American Standard for Dietary Supplements, the Ann Arbor, Mich.-based organization says May 8. In addition to updating the NSF/American National Standards Institute Standard 173 for supplements to include the GMPs, the new version of the standard also references the Adverse Event Reporting requirements, which went into effect December 2007. The NSF standard is used to analyze and evaluate supplements to ensure they contain no undeclared ingredients or unacceptable levels of contaminants, the group says...

You may also be interested in...



Whey Protein Recalled Under Salmonella Suspicion May Touch Supplements

A dairy ingredient manufacturer with whey protein and other products on recall for possible salmonella contamination may have widespread distribution

Are Trial Sponsors Treading On Investigators’ Toes In Decentralized Trials?

The Danish regulator’s experience with reviewing and inspecting decentralized elements in clinical trials highlights concerns around the blurring of lines that divide the roles and responsibilities of sponsors and trial investigators.

Nichi-Iko Aims To Regroup As It Enters Turnaround Process

Japan’s Nichi-Iko has formally entered a business turnaround alternative dispute resolution process that will see the company outline a business rehabilitation plan involving management restructuring and a fresh profit structure, following financial underperformance in the wake of recent quality issues.

Topics

UsernamePublicRestriction

Register

PS101644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel